Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,559 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06940869Enrolling by invitation
Reproductive health registry for rheumatic conditions
This study creates a registry to better understand pregnancy outcomes in people with autoimmune or rheumatic conditions. If you are aged 12 to 55, can become pregnant (or are currently pregnant or planning a pregnancy), and receive care at Duke Health, you may be eligible to join.
Durham, North CarolinaAges 12–55 - NCT06940596Recruiting
Comparing diets and therapies for irritable bowel syndrome
This study compares different dietary and behavioral treatments to find out which works best for different people with irritable bowel syndrome (IBS). You'll be asked to follow a specific treatment program to see how it affects your symptoms.
Melbourne, VictoriaAges 18 years+ - NCT06932679Recruiting
How people with Parkinson’s cross obstacles
This study looks at how people with and without Parkinson’s disease see and step over obstacles while walking. It aims to understand differences in perception and movement to help improve safety and mobility for people with Parkinson’s.
HaifaAges 20–80 - NCT06936111Recruiting
Can extra cholesterol-lowering help after a stent?
This trial looks at whether stronger cholesterol-lowering medicine can reduce the risk of future heart problems in people who already have a stent. It focuses on people who still have other mildly narrowed spots in their arteries.
ShanghaiAges 18–75 - NCT06939712Recruiting
Online mental health program for Crohn's patients
This study tests an online program that uses positive psychology to help improve mental health and quality of life in people with Crohn's disease who have mild anxiety or depression. The program is done over the internet, so you can join from home.
Hangzhou, ZhejiangAges 18–75 - NCT06941519Recruiting
Addressing social needs to improve health in adults with chronic conditions
This program helps adults with multiple health conditions who also face social challenges like food or housing problems. It connects you with support to improve your health and close gaps in your care.
Pleasanton, CaliforniaAges 18 years+ - NCT06383247Recruiting
Precision TMS for parkinson's motor symptoms
This trial tests a precise form of brain stimulation (called TMS) to see if it can improve movement problems like stiffness, slowness, or tremors in people with Parkinson's disease. Participants must have a stable medication routine and no metal implants or brain surgery history.
Hefei, AnhuiAges 40 years+ - NCT05786235Recruiting
Pregnant people with or without antiphospholipid antibodies
This study is looking at pregnancy outcomes in people who are pregnant and either have antiphospholipid antibody syndrome (APS) or do not have APS but do have prior full-term pregnancies. It may help doctors understand risks and how to manage pregnancies in these groups.
MilanAges 18–45 - NCT05896800Recruiting
Inhaled nitric oxide for moderate to severe COPD symptoms
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
Nanjing, JiangsuAges 40–75 - NCT06931535Recruiting
Arm cuff treatment for recent moderate back-of-brain stroke
This trial tests whether a simple, non-drug treatment (using a blood pressure cuff to briefly restrict blood flow to your arm) can help people with a recent moderate stroke in the back part of the brain. It aims to improve recovery by preparing the body to better handle the stroke damage.
ShenyangAges 18 years+ - NCT06928519Recruiting
Entacapone with Madopar for early Parkinson's
This study tests whether adding entacapone to Madopar (a common Parkinson's medication) safely improves symptoms in people with early-stage Parkinson's. It aims to see if the combination works better than Madopar alone.
Nanning, GuanxiAges 18–80 - NCT06928506Recruiting
Study of Hi-OxSR for Long COVID treatment
This study tests whether a treatment called Hi-OxSR can help with lingering symptoms of Long COVID, especially problems with thinking and memory. You may be eligible if you've had COVID-19 at least 3 months ago and still have ongoing symptoms that affect your thinking.
Edmonton, AlbertaAges 18 years+ - NCT06930638RecruitingPhase 2
MitoQ and leg conditioning for stroke recovery
This study tests whether a supplement called MitoQ and a special leg-pumping technique can improve blood vessel health in people who had a stroke at least 6 months ago. It may help your body recover better after a stroke.
Milwaukee, WisconsinAges 18–85 - NCT06924359Recruiting
Eye scans and blood tests for early Alzheimer's detection
This study uses special eye scans and blood tests to find early signs of Alzheimer's disease. It aims to detect the disease before memory loss becomes severe, so treatment can start sooner.
BeijingAges 50 years+ - NCT06916507Recruiting
Early treatment with a new Parkinson's drug
This study tests a new form of Parkinson's medication given through a pump to see how well it works in everyday life for people in the early stages of advanced Parkinson's. It may help control symptoms and improve daily function.
Allensbach, Baden-WurttembergAges 18–67 - NCT06918808RecruitingPhase 2
Stem cell therapy for Crohn's fistula healing
This trial tests if a special stem cell treatment (called DB-3Q bmMSC-EVs) can help heal fistulas caused by Crohn's disease. It's for people who have already tried other treatments and still have actively draining fistulas.
Aurora, ColoradoAges 18–75 - NCT06918938Recruiting
Vision and movement study for Parkinson disease
This study looks at how Parkinson disease affects the connection between vision and movement. You will be asked to view a computer screen and perform simple tasks to help researchers understand these changes.
Taipei, Zhongzheng Dist.Ages 18 years+ - NCT06915324Recruiting
Electric brain stimulation for Lyme disease cognitive issues
This study tests if a gentle electrical current applied to the scalp can improve thinking problems (like slow processing speed) that continue after Lyme disease treatment. It could help you if you have mental fog or memory trouble that hasn't gone away with antibiotics.
San Francisco, CaliforniaAges 18–70 - NCT06919302Recruiting
Digital heart health app for heart disease patients
This study tests a digital heart health app combined with lifestyle coaching to help people with heart disease or diabetes manage their cholesterol and overall heart health. It aims to see if the app can improve outcomes for people already taking a statin.
Toronto, OntarioAges 45 years+ - NCT06918145Enrolling by invitation
LVA surgery for Alzheimer's disease
This study tests a surgery called lymphaticovenous anastomosis (LVA) as a possible treatment for Alzheimer's disease. The surgery connects tiny lymph vessels to veins to help clear waste from the brain.
Beijing, Beijing MunicipalityAges 50–85 - NCT06920134Recruiting
Spinal cord stimulation for blood pressure in Parkinson's disease
This trial tests if electrical stimulation of the spinal cord can help manage blood pressure drops (orthostatic hypotension) in people with Parkinson's and related conditions. It might make daily activities like standing and walking easier.
Lausanne, Canton of VaudAges 18–90 - NCT06909773Recruiting
COPD testing in people with heart disease
This study looks for undiagnosed COPD in people with heart conditions like coronary heart disease, atrial fibrillation, or chronic heart failure. If you have heart disease and are over 40, you may join to see if you also have COPD and benefit from combined care.
AnqingAges 40 years+ - NCT06902558RecruitingPhase 2
Study of ABBV-CLS-628 for adults with polycystic kidney disease
This trial tests a new drug, ABBV-CLS-628, for people with autosomal dominant polycystic kidney disease (ADPKD). The goal is to see if it slows kidney function decline and is safe to use.
Birmingham, AlabamaAges 18–55 - NCT06904261RecruitingPhase 3
Study of migalastat for children with Fabry disease
This trial tests if the oral drug migalastat is safe and works for children aged 2 to under 12 with a specific type of Fabry disease. It may be an option if your child has not been on enzyme therapy recently and has a compatible gene variant.
Atlanta, GeorgiaAges 2–11
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,559 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.